Relaxo Footwears Ltd
RELAXORelaxo Footwears Ltd's earnings have outrun its stock. EPS grew +5.3% in a year against a −13.4% price move.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is in a downtrend (130 weeks in) while the P/E sits at the 30th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +21.4% year on year, and 180% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Relaxo Footwears Ltd trades at ₹440, in a downtrend and 130 weeks into that stage. That is +17.7% against its own 200-day average. It sits at 77% of a 52-week range of ₹250 to ₹497. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 12 straight weeks.
Today the stock is in a downtrend — week 130 of stage 4, confirmed. At ₹440 it trades +17.7% versus its 200-day average and sits at 77% of its 52-week range (₹250–₹497).
Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +128% while the NIFTY 500 moved +274% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 12 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 30th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Relaxo Footwears Ltd trades at 56.0× P/E, near the bottom of its own range — cheaper only 30% of the time. Its long-run median P/E is 67.9×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 56.0× is near the bottom of its own range — cheaper only 30% of the time, against a long-run median of 67.9× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +5.3% against a −13.4% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −17.6%/yr price move, ~−9.3%/yr came from earnings growth and ~−8.3 pp from the multiple (compressing); over 10y, of the +6.2%/yr price move, ~+3.9%/yr came from earnings growth and ~+2.3 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Relaxo Footwears Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 11.1% — the per-curve reads carry the story. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −3.2% | −1.0% | +2.8% | +4.9% |
| Profit | +5.3% | +5.1% | −9.3% | +4.1% |
| EPS | +5.3% | +5.1% | −9.3% | +3.7% |
| Share price | −13.4% | −21.3% | −17.6% | +6.2% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
39.0/100 — rank 3 of 6 in Footwear · 94% evidence confidence
Relaxo Footwears Ltd scores 39.0 out of 100 against the 6 companies it is compared with in Footwear, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 14.2 + 12.8 + 2.5 + 9.5 = 39. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Relaxo Footwears Ltd reported ₹751 Cr of revenue in the Mar 26 quarter, +8.1% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 4.9% a year. The last full year, FY26, came in at ₹2,702 Cr. The last four reported quarters add to ₹2,702 Cr.
Relaxo Footwears Ltd reported ₹751 Cr of revenue in the Mar 26 quarter, +8.1% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 4.9% a year. The last full year, FY26, came in at ₹2,702 Cr. The last four reported quarters add to ₹2,702 Cr.
FY26 revenue came in at ₹2,702 Cr (−3.2% on the year), capping 10 years at 4.9% compound. The latest quarter (Mar 26) printed ₹751 Cr, +8.1% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged −2.9% growth against the decade's 4.9% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −3.1% over the last 4 quarters against −3.7%/yr over the last 8 — stabilising; TTM profit +5.9% vs −5.1%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 17.0% this quarter (+1.0 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Relaxo Footwears Ltd's operating margin is 17.0% in the Mar 26 quarter, +1.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 12.0% to 21.0%. The current quarter sits inside that band.
Relaxo Footwears Ltd's operating margin is 17.0% in the Mar 26 quarter, +1.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 12.0% to 21.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 17.0%, +1.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 12.0%–21.0%.
Why the margin moved: operating margin went +0.4 pp year on year while gross margin went +1.9 pp — the gain came mostly from the gross line: input costs and pricing.
→ Margins held — did that reach the bottom line? Next: profit +21.4% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Relaxo Footwears Ltd earned ₹68.0 Cr of net profit in the Mar 26 quarter, +21.4% year on year. Full-year FY26 profit was ₹179 Cr. The 10-year compound rate is 4.1%. That is 9.1% of the quarter's revenue. The same quarter a year earlier earned ₹56.0 Cr.
Relaxo Footwears Ltd earned ₹68.0 Cr of net profit in the Mar 26 quarter, +21.4% year on year. Full-year FY26 profit was ₹179 Cr. The 10-year compound rate is 4.1%. That is 9.1% of the quarter's revenue. The same quarter a year earlier earned ₹56.0 Cr.
Mar 26 profit was ₹68.0 Cr, +21.4% year on year. On the full year, FY26 printed ₹179 Cr (+5.3%), and the 10-year compound rate is 4.1%.
Why profit moved: revenue contributed +8.1% and the margin +1.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +3.0% vs revenue −2.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
→ Profit rose — but did the cash follow? Next: 180% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 180% of Relaxo Footwears Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹348 Cr of operating cash against ₹179 Cr of profit. After ₹221 Cr of capital spending, ₹127 Cr was left as free cash.
FY26: operating cash of ₹348 Cr against reported profit of ₹179 Cr, leaving free cash of ₹127 Cr after ₹221 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 180% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 180%: the cash cycle stretched 37 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
→ So follow the cash to where it goes. Next: a 138-day cycle and ₹685 Cr of building.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Relaxo Footwears Ltd's cash conversion cycle runs 138 days in FY26, up from 101 days in FY21. Capital spending ran ₹685 Cr over the last 3 years. At FY26 sales of ₹2,702 Cr each day of that cycle holds about ₹7.4 Cr, so roughly ₹1,022 Cr sits inside the business at any moment.
FY26: debtors at 40 days, inventory at 184 days — roughly 6.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 138 days, looser than FY21's 101.
The full loop: cash goes out to suppliers and production on day 0; stock waits 184 days to sell; customers pay about 40 days after that; and suppliers themselves are paid at 87 days — netting out to the 138-day cycle.
In money terms: at FY26 sales of ₹2,702 Cr, each day of the cycle holds about ₹7.4 Cr — so the 138-day loop keeps roughly ₹1,022 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹685 Cr over the last 3 fiscal years against ₹462 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹97.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 11% and the ROIC − WACC spread is −4.5 pp.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Relaxo Footwears Ltd earns a ROCE of 11% in FY26. That is up from a trough of 11% in FY25. Return on invested capital clears the cost of that capital by −4.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 6.6% net margin on 0.92× asset turns.
FY26 ROCE is 11%, recovered from a FY25 trough of 11% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 6.6% net margin × 0.92× asset turns × 1.34× balance-sheet leverage ≈ 8.1% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 7.5% − 12.0% = a −4.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.11.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Relaxo Footwears Ltd carries total debt of ₹233 Cr against shareholder equity of ₹2,206 Cr as of Mar 26, a debt-to-equity of 0.11 — effectively unlevered. On the annual view that ratio went from 0.10 in FY22 to 0.11 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹233 Cr against shareholder equity of ₹2,206 Cr — a debt-to-equity of 0.11. On the annual view, debt-to-equity went from 0.10 (FY22) to 0.11 (FY26). The returns on this page are earned, not borrowed.
→ Who owns this, and are they adding or leaving? Next: the register is quiet.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Relaxo Footwears Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.1 points over the same window, to 9.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −0.3 points over 8 quarters to 3.1%; Domestic institutions: +0.1 points over 8 quarters to 9.7%; Promoters: +0.0 points over 8 quarters to 71.3%.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Relaxo Footwears Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Relaxo Footwears Ltd this page | 56.0× | ₹10,031 Cr | Improving | |||
| Metro Brands Ltd | 67.7× | ₹27,853 Cr | Mixed | |||
| Bata India Ltd | 52.7× | ₹8,868 Cr | Mixed | |||
| Redtape Ltd | 29.1× | ₹7,008 Cr | Improving | |||
| Campus Activewear Ltd | 48.7× | ₹6,619 Cr | — | — | — | — |
| Mirza International Ltd | — | ₹485 Cr | No read |
Frequently asked questions
What is Relaxo Footwears Ltd's share price today?
Relaxo Footwears Ltd trades at ₹440, −13.4% over the past year. The company is valued at ₹10,031 Cr. The stock sits at 77% of its 52-week range of ₹250–₹497, +17.7% versus its 200-day average. On the tape, the price is in a downtrend, 130 weeks in. — as of 24 July 2026.
What were Relaxo Footwears Ltd's latest quarterly results?
Relaxo Footwears Ltd reported revenue of ₹751 Cr and net profit of ₹68.0 Cr for the Mar 26 quarter. Revenue rose 8.1% and profit rose 21.4% year on year. Earnings per share were ₹2.72. The operating margin was 17.0%, 1.0 pp higher than a year earlier. — as of 24 July 2026.
What is Relaxo Footwears Ltd's revenue?
Relaxo Footwears Ltd reported revenue of ₹751 Cr in the Mar 26 quarter, +8.1% year on year. For the full FY26 fiscal year, revenue was ₹2,702 Cr (−3.2%). Over the last 10 years revenue compounded at 4.9% a year. — as of 24 July 2026.
What is Relaxo Footwears Ltd's profit?
Relaxo Footwears Ltd earned ₹68.0 Cr of net profit in the Mar 26 quarter, +21.4% year on year. Full-year FY26 profit was ₹179 Cr. The operating margin ran 17.0% in the latest quarter. — as of 24 July 2026.
What is Relaxo Footwears Ltd's market cap?
Relaxo Footwears Ltd's market capitalisation is ₹10,031 Cr at a share price of ₹440. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is Relaxo Footwears Ltd's P/E ratio?
Relaxo Footwears Ltd trades at a P/E of 56.0×, at the 30th percentile of its own 10-year range, against a long-run median of 67.9×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does Relaxo Footwears Ltd pay a dividend?
Yes — Relaxo Footwears Ltd's dividend payout was 49% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 24 July 2026.
Is Relaxo Footwears Ltd overvalued?
On its own history, Relaxo Footwears Ltd looks cheap against its own history: its P/E of 56.0× has been cheaper only 30% of the time in 10 years (long-run median 67.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 24 July 2026.
Is Relaxo Footwears Ltd growing?
Yes — Relaxo Footwears Ltd is growing: latest-quarter revenue +8.1% year on year, profit +21.4%, and the margin +1.0 pp at 17.0%. The 10-year compound rates are 4.9% (revenue) and 4.1% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is Relaxo Footwears Ltd performing?
Relaxo Footwears Ltd is in a downtrend, 130 weeks in. Its latest quarter's revenue rose 8.1% and profit rose 21.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 12 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is Relaxo Footwears Ltd in?
Mixed — no clean majority across the growth curves, ROCE holding at 11.1% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth −3.1% latest, profit growth +5.9% latest, eps growth +5.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is Relaxo Footwears Ltd in an uptrend?
No — the price is in a downtrend (week 130 of stage 4), trading +17.7% versus its 200-day average and at 77% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is Relaxo Footwears Ltd beating the market?
On recent form, yes — Relaxo Footwears Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 12 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +128% against the NIFTY 500's +274% — behind the index over the full window. — as of 24 July 2026.
Will Relaxo Footwears Ltd's share price go up?
This page publishes no price forecast for Relaxo Footwears Ltd. What it measures instead: the share price is ₹440, the price is in a downtrend 130 weeks in. Its P/E of 56.0× sits at the 30th percentile of its own 10-year range. — as of 24 July 2026.
Who owns Relaxo Footwears Ltd?
Promoters hold 71.3% of Relaxo Footwears Ltd, foreign institutions 3.1%, domestic institutions 9.7% and the public 15.9% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 24 July 2026.
Does Relaxo Footwears Ltd have too much debt?
No — Relaxo Footwears Ltd's debt-to-equity is 0.11, and operating profit covers the interest bill 17×. FY26 borrowings were ₹233 Cr against equity of ₹2,206 Cr. The returns on this page are earned, not borrowed — as of 24 July 2026.
What is Relaxo Footwears Ltd's capex?
Relaxo Footwears Ltd spent ₹685 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹221 Cr, with ₹97.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is Relaxo Footwears Ltd's cash flow?
Relaxo Footwears Ltd generated ₹348 Cr of operating cash flow in FY26 and ₹127 Cr of free cash flow after ₹221 Cr of capital spending. Reported profit that year was ₹179 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is Relaxo Footwears Ltd's profit real cash?
Yes — over the last 3 fiscal years, 180% of Relaxo Footwears Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹348 Cr against reported profit of ₹179 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 24 July 2026.
Where is Relaxo Footwears Ltd in its business cycle?
Relaxo Footwears Ltd's FY26 operating margin was 14.0%, against a 13-year band of 12.0%–21.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 17.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the Relaxo Footwears Ltd story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is Relaxo Footwears Ltd a stock worth studying right now?
This is not investment advice. The machine read: Relaxo Footwears Ltd's earnings have outrun its stock. EPS grew +5.3% in a year against a −13.4% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.